Women <35 years old and BMI <30 kg/m2 were identified as being high risk for OHSS by serum AMH level ≥40 pmol/L or AFC ≥23 and received a single subcutaneous bolus of kisspeptin-54 at doses of 3.2 to 12.8 nmol/kg (16, 17). This evidence concerns the gene AMH and ovarian hyperstimulation syndrome.